Technologies by Susan Thomas
Microfluidic Device Enables Prediction of T-Cell Ability to Home and Engraft to Disease Tissues
Only a fraction of infused T cells makes it into targeted tumors
9052
Sustained Lymphatic Drug Delivery System Potentially Improves Efficacy and Safety of Immunotherapy and Targeted Therapies
No effective lymphedema therapies currently exist and cancer immunotherapy lacks safety and efficacy
8637
Developing Tumor Immune Microenvironments via Engineered Hydrogel
A biomaterial-programmed method for preclinical in vivo cancer immunotherapy evaluation
A biomaterial-programmed method for preclinical in vivo cancer immunotherapy evaluation
8785
Novel Crosslinked Hydrogel Improves Efficacy and Side Effects of Cancer Treatment
An innovative immunotherapy method uses checkpoint inhibitors to advance current antitumor therapeutics
An innovative immunotherapy method uses checkpoint inhibitors to advance current antitumor therapeutics
8505